Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
주식 순위 #25706
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
주가
$2.09
마지막 동기화: 2022-03-21
시가총액
$47.04M
변동 (1일)
-0.48%
변동 (1년)
0.00%
국가
US
거래 Recro Pharma, Inc. (REPH)

카테고리

Recro Pharma, Inc. (REPH)의 주식 분할 이력
Recro Pharma, Inc. 주식 (심볼: REPH)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 21, 2026에 발생했습니다.
Aug 21, 2026 이전에 매수한 REPH 주식 1주는 현재 0주의 REPH 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할